HIT Consultant September 15, 2025
What You Should Know:
– Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and verified data from over 5,500 sites quickly and easily.
– The new capabilities fill an acute gap for sponsor decision-makers, arming them with the insights they need to quickly and confidently choose the right mix of sites for each trial.
Inato Unveils AI-Powered Site Selection to Transform Clinical Trial Accessibility
Inato is on a mission to bring clinical research to every patient, no matter where they live. The global technology company unites trial planning, site selection, and patient pre-screening in a single AI-enabled platform...
Today's Sponsors
Today's Sponsor